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Nonribosomal peptides (NRPs) are molecules produced by microorganisms that have a broad spectrum of
biological activities and pharmaceutical applications (e.g., antibiotic, immunomodulating, and antitumor
activities). One particularity of the NRPs is the biodiversity of their monomers, extending far beyond the 20
proteogenic amino acid residues. Norine, a comprehensive database of NRPs, allowed us to review for the first
time the main characteristics of the NRPs and especially their monomer biodiversity. Our analysis highlighted
a significant similarity relationship between NRPs synthesized by bacteria and those isolated from metazoa,
especially from sponges, supporting the hypothesis that some NRPs isolated from sponges are actually
synthesized by symbiotic bacteria rather than by the sponges themselves. A comparison of peptide monomeric
compositions as a function of biological activity showed that some monomers are specific to a class of activities.
An analysis of the monomer compositions of peptide products predicted from genomic information (meta-
genomics and high-throughput genome sequencing) or of new peptides detected by mass spectrometry
analysis applied to a culture supernatant can provide indications of the origin of a peptide and/or its
biological activity.
Nonribosomal peptides (NRPs) are molecules produced by
microorganisms and synthesized by huge multienzymatic com-
plexes (38, 41), called nonribosomal peptide synthetases
(NRPSs). These megaenzymes are organized into modules,
one for each amino acid to be built into the peptide product.
This is accomplished by division of each catalytic step into
specialized semiautonomous domains. The basic set of do-
mains (adenylation, thiolation, and condensation) within a
module can be extended by substrate-modifying domains, in-
cluding domains for substrate epimerization,  hydroxylation,
N methylation, and heterocyclic ring formation. The peptide
release is catalyzed by a thioesterase domain which can also, in
many cases, be involved in an intramolecular reaction leading
to a cyclic or partially cyclic peptide or, in fewer cases, in the
oligomerization of peptide units (iterative biosynthesis). NRPs
show a broad spectrum of biological activities and pharmaceu-
tical applications. They can harbor antimicrobial, immuno-
modulator, or antitumor activities. Cyclosporine (5), an immu-
nosuppressant drug widely used in organ transplantation,
daptomycin (60) (marketed in the United States under the
trade name Cubicin), used in the treatment of certain infec-
tions caused by Gram-positive bacteria, aminoadipyl-cysteinyl-
valine (ACV)-tripeptide, which is the precursor of cephalospo-
rin and penicillin (29), the most famous antibiotic, and also
bleomycin (57), used in the treatment of several cancers, are
some common examples of NRPs of high therapeutic impor-
tance. Two main structural traits distinguish these peptides
from ribosomally synthesized peptides: first, their primary
structure is more frequently cyclic (partially or totally)
branched or polycyclic rather than linear and, second, the
biodiversity of monomers incorporated in NRPs goes far be-
yond the 20 proteogenic amino acids residues. NRP monomers
include modified versions of the proteogenic amino acids (e.g.,
methylated, hydroxylated, and D-forms) but also other mono-
mers, such as, for example, 2-aminoisobutyric acid (Aib), hy-
droxyphenylglycine (Hpg), and 2,3-dihydroxybenzoic acid
(diOH-Bz). However, essential characteristics of this diversity
and its relationship with biological functions and producing
organisms have been poorly understood until now.
The development of the Norine database, the first resource
entirely dedicated to NRPs (8, 9), filled this gap. Based on
Norine data, we performed the first large-scale analysis of
about a thousand peptides which represent a total coverage of
more than 10,000 monomer occurrences, revealing the pres-
ence of as many as 500 different monomer types. A data-
mining analysis of the monomeric compositions of NRPs al-
lowed us to reveal a strong relationship between certain
monomeric characteristics of NRPs and their biological func-
tion and producing organism. In addition to providing a com-
prehensive overview of monomeric biodiversity in NRPs, this
work demonstrated (i) a dissimilarity of structural properties
between bacterial and fungal NRPs; (ii) a significant relation-
ship between NRPs synthesized by bacteria and those isolated
from metazoa, especially from sponges, supporting the hypoth-
esis that the peptides isolated from sponges are in reality syn-
thesized by symbiotic bacteria rather than by the sponges
themselves; and (iii) a certain monomer specificity to a class of
biological activities. Those observations are supported by suc-
cessful statistical predictions of biological activities of NRPs
based on their monomeric compositions.
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MATERIALS AND METHODS
NRP set. Here, we define the data sets we used in our analyses. We started
with the whole set of the first 1,071 peptides stored in the Norine database
(http://bioinfo.lifl.fr/norine). Based on the annotations of the Norine database,
we selected several training sets as described below.
First, we distinguished between curated and putative NRPs as annotated in the
Norine database. For curated peptides, either corresponding synthetase genes
have been identified or their nonribosomal origin has been universally accepted
by the scientific community, as is the case for polytheonamide, for example (32).
For putative peptides, there is no experimental evidence of their synthesis path-
way, and other characteristics, such as their nonlinear structure and/or found
nonproteogenic amino acids, suggest their nonribosomal origin. Examples are
oscillarin (27) and aurilide (62). Of the 1,071 Norine peptides, 790 (that is, nearly
three-quarters) are curated.
Second, some Norine peptides are considered variants belonging to the same
group. Until now, no universal definition of the NRP variants has been proposed.
Most of the time, peptides are called variants if they show similar compositions.
For example, surfactin (3) and [Val7]surfactin (44) differ by only one monomer
at position 7. More rarely, variants may have different structures and/or sizes,
such as cyclic gramicidin S (11), composed of 10 monomers, and linear grami-
cidin A (31), composed of 16 monomers. However, some peptides can also be
considered variants when they share a specific function or have features in
common. For example, pyoverdins (67) form a large group of siderophores (7)
produced by species of Pseudomonas or a related genus; they have a large
diversity in structure and monomeric composition but have features in common,
such as the presence of a fluorescent chromophore.
To reduce a bias in learning structural or compositional properties of NRPs
belonging to different groups, we eliminated close variants and kept only one
variant per group. For example, in some groups, only few monomers vary, and
therefore invariable monomers of these groups may be given an overestimated
significance. In order to identify groups for which we need to keep only one
representative variant, we computed an average distance between all variants of
the group (see the supplemental material). If the peptides of a given group were
similar, i.e., the average phylogenetic distance in the group was low, we kept only
one random member of this group; otherwise, we kept all the peptides of the
group. The 1,071 NRPs (790 curated) were divided into 183 groups (100 cu-
rated), of which 62 groups (24 curated) contain only one peptide. Among the 121
groups (76 curated) containing at least two variants, 9 (4 curated) showed a high
diversity (Table 1): dolastatines (47), guineamides (64), hymenamides (58), ka-
halalides (26), kapakahines (68), phakellistatins (42), pyoverdins (67), serrawet-
tins (35), and stylopeptides (6). For those groups, we kept all the variants in all
analyses. We want to mention that 130 peptaibols (16) are stored in the Norine
database, divided into 20 groups of variants. All the peptaibols are curated
NRPs. This means that there are 20 representative peptaibols among 290 (175
curated) representative NRPs. When we consider a data set containing only one
variant per group (except for the 9 groups mentioned above), we use the term
“excluding variants.” The NRP set excluding variants contains 290 peptides, and
the curated NRP set excluding variants contains 175 peptides.
Correlation coefficient. The correlation coefficient (CC) is computed in order
to evaluate the relationship between two data sets. It is comprised between 1
and 1; the closer the CC is to these extreme values, the more the data are
correlated. In two series, X (x1, . . ., xn) and Y (y1, . . ., yn), the CC is computed
as follow:
r

i1
n xi x  yi y

i1
n xi x2  
i1
n yi y2
In our case, X and Y will be either two monomeric distributions, i.e., the number
of monomer occurrences in two sets of NRPs, or two distributions of peptide
sizes.
RESULTS
The arrival of the Norine database provided us with the
possibility of obtaining a general overview of NRPs. Below we
present three analyses that we performed on Norine data.
First, we studied some general statistical characteristics of
NRPs, and then we focused on properties related to producing
organisms; finally, we analyzed the monomeric distribution
depending on biological activities. The observations that we
drew from these analyses should be used for predicting the
activities and origins of newly identified products.
General statistics. To avoid a bias in our analysis, we chose
to restrict the data set for general statistics to the curated
peptides excluding variants, which refers to 175 peptides (see
Materials and Methods). However, the results obtained with
the total set of NRPs lead to the same conclusions (data not
shown).
(i) How variable are nonribosomal peptide structures? It
can be deduced from Norine data that nonlinear structures
represent nearly three-quarters of the NRP structures (Fig. 1).
The majority (64%) of NRPs contain at least one cycle, but
only a few peptides (1%) possess only branchings, and up to
8% present complex structures with overlapping cycles and
branching. Those complex structures are found mainly in gly-
copeptides (15), a large group of antibiotics, the most famous
of which is vancomycin (Fig. 2), used in treatment of infections
caused by Gram-positive bacteria (28).
(ii) What is the size of a nonribosomal peptide? We have
defined the size of an NRP to be the total number of mono-
mers, with fatty acids in lipopeptides being considered individ-
ual monomers, as they are most frequently added as a single
block by a condensation domain (as in arthrofactin synthesis
[51]), or by using a single module in PKS-NRPS hybrid syn-
thetases (as in the mycosubtilin synthetase [17]). As the syn-
thetases are generally constituted of as many modules as
monomers incorporated into the peptide (except in the itera-
tive mode of synthesis), the sizes of NRPs are limited (Fig. 3).
The most frequent sizes are 7 to 9 monomers, sizes shared by
about one-third of the set. The sizes vary between 2 and 23
monomers, except for polytheonamide B (not shown in Fig. 3),
which has 49 monomers. Polytheonamide B has been extracted
FIG. 1. Distribution of primary structures in curated peptides ex-
cluding variants (175 peptides).
TABLE 1. Repartition of NRPs in groups showing great diversity
Group All NRPs(n  9)
Only curated NRPs
(n  4)
Dolastatines 4 4
Kahalalides 16 16
Pyoverdins 57 57
Serrawettins 2 2
Guineamides 6
Hymenamides 10
Kapakahines 5
Phakellistatins 14
Stylopeptides 2
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from the marine sponge Theonella swinhoei (25), but its syn-
thesis process is not known. However, it contains several non-
proteogenic and D-amino acids that suggest that its synthesis is
nonribosomal (32).
(iii) What are the most frequently found monomers in non-
ribosomal peptides? In addition to having specific primary
structures, NRPs contain nonproteogenic amino acids and
other monomers. Among 1,725 monomers contained in 175
curated peptides excluding variants, 1,614 are incorporated
and/or modified directly by nonribosomal peptide synthetases,
44 are lipids, 11 are carbohydrates, 5 are polyketides, and 51
are of other or unknown origins. Proteogenic L-amino acids
represent 40% of monomers found in NRPs. The most fre-
quent monomer in curated peptides excluding variants is
2-aminoisobutyric acid (Aib) (Fig. 4). The monomer Aib is
characteristic of peptaibols (2), which are linear antibiotics
produced only by fungi. The Norine database contains 130
peptaibols, forming 20 groups of variants (see Materials and
Methods), all of which contain at least one Aib residue. Aib
can occur several times in the same peptaibol, on average 6
times per peptide, which explains why Aib is the most frequent
monomer in Norine NRPs. Note that serine (Ser), threonine
(Thr), and their derivatives are very frequent in NRPs. These
amino acids present a hydroxyl function that allows the forma-
tion of an additional chemical bond in order to obtain nonlin-
ear primary structures. For example, in syringomycins (56), the
hydroxyl group of serine is responsible for the branching, and
the hydroxyl group of two threonines is used to form two cycles
in actinomycin D (45). Many amino acids appear in their D-
form in NRPs. D-Monomers are epimerized mainly by a spe-
cific domain of the synthetase or, in some cases, can be directly
incorporated into their D-form, as was shown for arthrofactin
synthesis (51). The monomer isomery can play an important
role in a peptide’s structure and properties, also by limiting
protease degradation. Nonproteogenic amino acids such as
2,4-diaminobutyric acid (Dab) or ornithine (Orn) and deri-
vates are often found in NRPs, for example, in marinobactins
(39) or pyoverdins (67), respectively.
Finally, it is interesting to note that the two proteogenic
amino acids containing the thiol function are underrepre-
sented in NRPs. Methionine (Met) is present in only one
curated peptide, oscillamide B (55), synthesized by bacteria,
and in four putative peptides extracted from sponges (hali-
gramides A and B [48], hymenamide F [33], and phakellistatin
5 [43]). Cysteine (Cys) occurs in the famous ACV (the peni-
cillin precursor) synthesized by both bacteria and fungi but also
occurs in 9 bacitracins (40) and in different siderophores (cu-
rated or not), such as pyochelin and related compounds (wata-
semycin, thiazostatin, aeruginoic acid, desferriferrithiocin,
micacocidin, yersiniabactin, and anguibactin) (7), synthesized
by bacteria where Cys forms a cycle with another monomer.
The high reactivity of the sulfhydryl group may explain the low
representativeness of free cysteine in NRPs.
The Norine database provides an interface to query the
monomers composing nonribosomal peptides (see http:
//bioinfo.lifl.fr/norine/search_amino.jsp). The entire list of
monomers can be browsed, and information on each monomer
can be consulted.
Study of producing organisms. Most of the peptides stored
in the Norine database are isolated from inoculated media or
natural environments, but only a few are inferred from a syn-
thetase protein sequence (154 database peptides are linked to
synthetases). Until now, synthetase genes have been identified
only in bacteria and fungi; none have been identified in ar-
chaea or nonfungal eukaryotes. The major part of curated
Norine peptides (61%) are synthesized by bacteria, and 34% of
them are synthesized by fungi (Fig. 5). However, some pep-
tides are extracted from other organisms (5% of data), such as
sponges (like cyclotheonamides [20] and polytheonamides [25,
32] from Theonella), tunicates (like didemnins [66] isolated
from the Didemnidae), gastropoda (such as antitumor peptide
dolastatines [7] extracted from species of Dolabella), or even
plants (e.g., a putative cyclolinopeptide [46] from linseed oil).
In these cases, the NRPS genes have not been identified, but
based on the presence of unusual monomers and/or structural
features in these peptides, a nonribosomal origin can be hy-
pothesized. For example, didemnins form a group of cyclic
depsipeptides isolated from two groups of tunicates, Didemni-
dae and Polyclinidae, and show antibiotic, antitumor, and im-
munomodulating activities. Didemnins contain several unusual
monomers, such as isostatine (Ist) and hydroxyisovalerylpro-
pionyl (Hip), suggesting their nonribosomal origin (24). How-
ever, in the case of organisms other than bacteria and fungi,
FIG. 2. Monomeric structure of vancomycin. Hpg, hydroxyphenyl-
glycine; NMe-Leu, N-methylleucine; bOH-Cl-Tyr, beta-hydroxy-
chloro-tyrosine; Asn, asparagine; Dhpg, 3,5-dihydroxyphenylglycine;
D-Glc, D-glucose; Van, vancosamine.
FIG. 3. Size distribution of curated peptides excluding variants
(175 peptides). Polytheonamide B, composed of 49 monomers, does
not appear in the figure, as it is the only peptide known with more than
23 monomers.
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the hypothesis that NRPs are actually synthesized by symbiotic
bacteria cannot be excluded. Indeed, several recent studies
have shown that NRPs extracted from sponges are in fact
synthesized by symbiotic bacteria (for recent studies, see ref-
erences 30, 36, 53, and 70).
We compared properties of NRPs isolated from bacteria,
fungi, and metazoa, the last being mainly sponges. In this
study, we considered curated NRPs for bacteria and fungi and
all NRPs for metazoa. We did not use sets excluding variants
or curated metazoan NRPs in order to keep a significant num-
ber of peptides in each set. To begin, we studied the size
distribution of NRPs in the three groups of producing organ-
isms (Fig. 6). We observed that the NRP sizes are different
depending on the group (bacteria, fungi, or metazoa). For
example, both bacteria and metazoa display a peak for sizes 7
and 8, while those sizes are nearly absent in fungal peptides.
Numerous fungal peptides have a size between 14 and 20,
while few bacterial and no metazoan peptides have those sizes.
A peak for size 4 is shared by fungi and metazoa. However, the
high proportion of size 4 metazoan peptides comes from geo-
diamolides (10), a family of 19 variants extracted only from
sponges. We have computed the correlation coefficients (CCs)
(Materials and Methods) between size distributions of NRPs
synthesized by bacteria or fungi or extracted from metazoa
(Table 2). The closer the CC is to 0, the less the monomeric
distributions are related. This experiment confirms the previ-
ous observations that fungal NRPs are unrelated to both bac-
terial and metazoan NRPs (CC close to 0), while metazoan
NRPs can be related to bacterial NRPs (CC close to 1).
Furthermore, we have computed the CC between peptide
monomeric distributions depending on the producing organ-
ism. The results are shown in Table 3.
The CC between the monomeric distribution of NRPs syn-
thesized by bacteria and those synthesized by fungi is the low-
est observed, pointing out differences between the monomers
used by both (super)kingdoms. On the other hand, the CC
between the distributions of bacteria and metazoa is the high-
est, highlighting their similarity. Analyzing the monomers con-
tained in peptides of different (super)kingdoms confirms the
correlation coefficient tendency. For example, Aib (2-amino-
isobutyric acid), the characteristic monomer of peptaibols, oc-
curs in 131 fungal peptides, from which only one putative cyclic
antitumor peptide is not a peptaibol: chlamydocin (4). Only
one bacterial peptide of the Norine database, microcystin L-
Aib (21), contains an L-Aib and no metazoan peptide (see Fig.
4). Other monomers are specific to fungal NRPs and, more
FIG. 4. Thirty of the most frequently found monomers among curated peptides excluding variants (175 peptides). The monomers’ proportions
occurring in bacteria, fungi, and metazoa are represented. dhAbu, 2,3-dehydro-2-aminobutyric acid.
FIG. 5. Distribution of producing organisms for curated peptides
(790 peptides).
FIG. 6. Size distribution of curated peptides synthesized by bacte-
ria (n  488), curated peptides synthesized by fungi (n  269), and
peptides extracted from metazoa (n  218).
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precisely, to peptaibols, such as isovaline (Ival), occurring in 23
peptaibols, phenylalaninol (Pheol), occurring in 68 peptaibols,
Leucinol (Leuol), occurring in 43 peptaibols, and valinol
(Valol), occurring in 29 peptaibols. The C-terminal amino al-
cohol in the peptaibols plays an important role in liposome
permeabilization and ion channel formation (18).
Other monomers seem to be found only in bacterial NRPs
(Fig. 4), which have specific properties. The monomer hy-
droxyphenylglycine (Hpg) is present in 56 NRPs, all of them
produced by bacteria. This monomer is the only amino acid
able to form 5 bonds with other monomers by oxidative ring
closure. Hpg is usually found in peptides with complex primary
structures, forming overlapping cycles and branching, such as
vancomycin (Fig. 2) (28), balhimycin (49), decaplanin (54),
eremomycin (22), and galacardin (63). Other monomers spe-
cific to bacteria are chromophores (Chr), which occur mainly
in siderophores, except for actinomycins.
Study of biological activity. (i) Statistical results. In this
section, we present a statistical analysis of some peptide char-
acteristics depending on the peptide’s biological activity. Here
we consider all the variants because, in spite of their close
compositions and structures, two variants can exhibit different
activities. For example, actinomycin D is known to have anti-
biotic and antitumoral activities, but for the majority of other
actinomycin variants, an antitumoral activity has not been re-
ported. Figure 7 shows the distribution of six main activities
found in curated peptides from the Norine database. Note
that some peptides can show more than one activity. For
example, there are 9 curated peptides in the Norine data-
base that present both antibiotic and immunomodulator ac-
tivities (such as edeines [12]) and 14 didemnins (66) that
present three activities, antibiotic, antitumor, and immuno-
modulator.
We analyzed the monomeric distribution of NRPs depend-
ing on their activities. The distribution of the 30 most frequent
monomers found in the Norine database-curated siderophores
are presented in Fig. 8.
At neutral and alkaline pHs, ferric ions form insoluble poly-
meric hydroxide complexes that cannot be assimilated by mi-
croorganisms. To tackle this low iron bioavailability, many
bacteria and fungi biosynthesize and excrete high-affinity iron
chelators known as siderophores. A common structural trait of
most of these molecules is the presence of three bidentate
groups which can ensure the 6-fold coordination of the ferric
iron. Catecholate, hydroxamate, and hydroxycarboxylate
groups are the three found most frequently that are able to
play this role in the coordination of iron. Different monomers
of NRPS products harbor such groups. For example, 2,3-dihy-
droxybenzoate (diOH-Bz, often denoted Dhb, which may re-
sult in confusion with another monomer, dehydrobutyrin,
present in ribosomal bacteriocins like nisin or subtilin [19]),
found in enterobactin or bacillibactin (1), or the chromophore
of pyoverdins (ChrP, a dihydroxyquinoline group which results
from the condensation and subsequent modification of diami-
nobutyric acid, tyrosine, and a dicarboxylic acid or its monoamide
[7]) contains a catecholate group. N-Formyl-N-OH-orni-
thine (Fo-OH-Orn), found in ornibactins (61), N-acetyl-N-
OH-ornithine (Ac-OH-Orn), found in aquachelins (69), N-
OH-cyclo-ornithine (OH-cOrn), found in pseudobactins
(65), OH-histidine (OH-His), found in corrugatin (50), and
OH-lysine (OH-Lys), found in mycobactins (59) all contain an
hydroxamate group. OH-aspartate (OH-Asp) of the azotobac-
tin D (13) contains a hydroxycarboxylate group. Note that
these monomers appear in the 30 most frequent siderophore
monomers (Fig. 8). We also analyzed the monomeric distribu-
tion of NRPs in the other five classes of main activities (data
not shown). The results suggest that the monomeric composi-
tion of a peptide can be used as a determiner of its biological
activity. From this observation, we developed a method helping
to predict the biological activity of a peptide from its mono-
meric composition.
(ii) Toward the prediction of biological activities. For each
monomer of the database, we precomputed its frequency in
each of the six activity classes. Then, for a given peptide, we
computed the average frequency of its monomers to appear
within each activity class and then deduced P values reflecting
the probability of the peptide belonging to each class. The
lower the P value for a given activity class, the more likely the
peptide is to present this given activity.
We tested this method on several NRPs which have not yet
been annotated in the Norine database. Table 4 gives some
examples of resulting predictions.
Orfamide is a surfactant showing antibiotic activity (23). A
TABLE 2. Correlation coefficients between size distributions of
NRPs synthesized by bacteria or fungi or
extracted from metazoa
Organism 1 Organism 2 CC
Bacteria (488 peptides) Fungi (269 peptides) 0.236
Bacteria (488 peptides) Metazoa (218 peptides) 0.817
Fungi (269 peptides) Metazoa (218 peptides) 0.254
TABLE 3. Correlation coefficients between monomeric
distributions of NRPs synthesized by bacteria or
fungi or extracted from metazoa
Organism 1 Organism 2 CC
Bacteria (488 peptides) Fungi (269 peptides) 0.252
Bacteria (488 peptides) Metazoa (218 peptides) 0.534
Fungi (269 peptides) Metazoa (218 peptides) 0.359
FIG. 7. Repartition of six main biological activities displayed by
curated peptides in the Norine database (790 NRPs).
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significant P value of 3.4E4 is obtained for this peptide for
the surfactant class, which suggests its surfactant properties.
Fuscachelin is a nonribosomal siderophore (14), for which our
method provided a strong indication. Aibellin is an antibiotic
NRP (34). The P value obtained for the antibiotic class is close
to 0, accurately predicting the biological activity of aibellin.
These results suggest that the monomeric compositions of pep-
tides can be of great help in predicting their biological activi-
ties.
DISCUSSION
General statistics. NRPs have numerous particularities.
First, more than 500 different monomers are found in those
peptides. Fatty acids, carbohydrates, and nonproteogenic
amino acids are often incorporated in NRPs. We showed that
in NRPs, a large part of monomers appear in their D-form. The
D-residues play an important role in the structural conforma-
tion of the peptide, crucial for its biological activity and resis-
tance against degradation process. NRPs can have a linear
primary structure (less than 30% of peptides in the Norine
database) but often present a more complex primary structure,
including branchings and cycles. These nonlinear structures
are essential for NRPs to have important biological activities,
such as antibiotic and antitumor activities, preserving mole-
cules from being degraded by proteases, which is essential for
their biological functions.
Study of producing organisms. NRPS genes are experimen-
tally identified only for bacteria and fungi. In this paper, we
showed that NRPs produced by bacteria and those produced
by fungi present different characteristics. The monomers used
by bacteria are very different from those used by fungi. In
addition, the NRP sizes are also very different for bacterial and
fungal NRPs. These results showed that monomeric and other
features of NRPs provide strong indications of their bacterial
or fungal origin.
In addition to NRPs from fungi and bacteria, various pep-
tides extracted from other organisms, such as metazoa, are
believed to have a nonribosomal origin with regard to the
presence of nonproteogenic amino acids (as in apramides [37],
containing N-methyl-glycine-thiazole, or the cyclic barang-
amides [52], containing D-alloisoleucine) or their nonlinear
structure. The current hypothesis is that the peptides extracted
from metazoa are in fact produced by symbiotic bacteria rather
than the metazoa themselves. Many recent papers tend to
confirm this hypothesis by experimental validation of special
cases of symbiosis (30, 36, 53, 70). In this paper, we have
shown that monomers and structural features of NRPs pro-
duced by bacteria and those isolated from metazoa are very
similar, which provides a supplementary argument support-
ing this hypothesis or the idea of a potential transfer of
bacterial genes to metazoan genomes.
Study of biological activities. NRPs harbor a large spectrum
of important biological activities. In this paper, we demon-
strated that each activity class is associated with some specific
monomers. By using frequencies of monomers in each activity
class, we showed that the monomeric composition of a peptide
FIG. 8. Repartition of 30 of the most frequently found monomers in Norine database-curated siderophores (88 peptides). Hse, homoserine;
ChrA, azotobactin chromophore; ChrI, isopyoverdin chromophore; Put, putrescine.
TABLE 4. Examples of biological activity predictions for some NRPs not annotated in the Norine database
Tested NRP Known activity(ies)
P value obtained for the indicated class of activity
Antibiotic Antitumor Immunomodulator Siderophore Surfactant Toxin
Orfamide Surfactant, antibiotic 0.46 0.52 0.86 0.68 3.40E04 0.29
Fuscachelin Siderophore 0.65 0.82 0.96 4.90E05 0.99 0.99
Aibellin Antibiotic 1.0E30 0.98 0.97 0.97 0.97 0.93
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can be an indicator of its biological activities. This can be of
great interest for the study of new NRPs and can provide
guidance for experimental studies.
Conclusion. For the last decade, the interest in NRPs and
their biosynthetic enzymes has been considerably increased, as
witnessed by an exponentially growing number of publications
in this field. These peptides, indeed, are or can be used in many
existing or potential biotechnological and pharmaceutical ap-
plications. A major part of published reviews focus on synthesis
enzymes or on a genomic analysis, and much less work has
been devoted to the global diversity of NRPs themselves. This
situation led us to develop the Norine database, which is the
only public resource devoted to NRPs and currently contains
more than a thousand peptides. This tool allowed us to review,
for the first time, the remarkable monomer diversity of these
compounds. To our knowledge, no extensive study of mono-
mers incorporated into NRPs has previously been done. In this
paper, we presented the first large-scale analysis of monomers
incorporated in NRPs. In addition to providing an overview of
this biodiversity, this work demonstrated (i) a dissimilarity of
structural properties between bacterial and fungal NRPs, (ii) a
significant relationship between NRPs synthesized by bacteria
and those isolated from metazoa, especially from sponges,
supporting the hypothesis that the peptides isolated from
sponges are in reality synthesized by symbiotic bacteria rather
than by the sponges themselves, and (iii) a certain monomer
specificity to classes of biological activities. An analysis of the
monomer compositions of peptide products predicted from
genomic information (metagenomics and high-throughput ge-
nome sequencing) can provide an indication of the origin of a
peptide and/or its biological activity. Furthermore, new pep-
tides detected by mass spectrometry analysis applied to a cul-
ture supernatant or carried out directly on colonies could be
studied in the same way, leading to predictions concerning
their origin or activities. Finally, those observations can be of
great interest for developing combinatorial biosynthesis of
NRPS and for the design of more-active antibiotic, immuno-
modulator, or anticancer drugs.
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